481 related articles for article (PubMed ID: 23533060)
1. Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis.
Johansson A; Faber F; Kniebühler G; Stepp H; Sroka R; Egensperger R; Beyer W; Kreth FW
Lasers Surg Med; 2013 Apr; 45(4):225-34. PubMed ID: 23533060
[TBL] [Abstract][Full Text] [Related]
2. Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX.
Beck TJ; Kreth FW; Beyer W; Mehrkens JH; Obermeier A; Stepp H; Stummer W; Baumgartner R
Lasers Surg Med; 2007 Jun; 39(5):386-93. PubMed ID: 17565715
[TBL] [Abstract][Full Text] [Related]
3. Photobleaching-based method to individualize irradiation time during interstitial 5-aminolevulinic acid photodynamic therapy.
Hennig G; Stepp H; Johansson A
Photodiagnosis Photodyn Ther; 2011 Sep; 8(3):275-81. PubMed ID: 21864802
[TBL] [Abstract][Full Text] [Related]
4. Low dose 5-aminolevulinic acid: Implications in spectroscopic measurements during brain tumor surgery.
Haj-Hosseini N; Richter JC; Hallbeck M; Wårdell K
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):209-14. PubMed ID: 25818546
[TBL] [Abstract][Full Text] [Related]
5. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
[TBL] [Abstract][Full Text] [Related]
6. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
Tyrrell JS; Campbell SM; Curnow A
Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
[TBL] [Abstract][Full Text] [Related]
7. ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment.
Stepp H; Beck T; Pongratz T; Meinel T; Kreth FW; Tonn JCh; Stummer W
J Environ Pathol Toxicol Oncol; 2007; 26(2):157-64. PubMed ID: 17725542
[TBL] [Abstract][Full Text] [Related]
8. Singlet oxygen model evaluation of interstitial photodynamic therapy with 5-aminolevulinic acid for malignant brain tumor.
Izumoto A; Nishimura T; Hazama H; Ikeda N; Kajimoto Y; Awazu K
J Biomed Opt; 2019 Dec; 25(6):1-13. PubMed ID: 31838789
[TBL] [Abstract][Full Text] [Related]
9. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors.
Johansson A; Palte G; Schnell O; Tonn JC; Herms J; Stepp H
Photochem Photobiol; 2010; 86(6):1373-8. PubMed ID: 20854414
[TBL] [Abstract][Full Text] [Related]
11. Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.
Boere IA; Robinson DJ; de Bruijn HS; Kluin J; Tilanus HW; Sterenborg HJ; de Bruin RW
Photochem Photobiol; 2006; 82(6):1638-44. PubMed ID: 16879035
[TBL] [Abstract][Full Text] [Related]
12. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.
Lange N; Jichlinski P; Zellweger M; Forrer M; Marti A; Guillou L; Kucera P; Wagnières G; van den Bergh H
Br J Cancer; 1999 Apr; 80(1-2):185-93. PubMed ID: 10389995
[TBL] [Abstract][Full Text] [Related]
13. Calcitriol enhances 5-aminolevulinic acid-induced fluorescence and the effect of photodynamic therapy in human glioma.
Chen X; Wang C; Teng L; Liu Y; Chen X; Yang G; Wang L; Liu H; Liu Z; Zhang D; Zhang Y; Guan H; Li X; Fu C; Zhao B; Yin F; Zhao S
Acta Oncol; 2014 Mar; 53(3):405-13. PubMed ID: 24032442
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review).
Friesen SA; Hjortland GO; Madsen SJ; Hirschberg H; Engebraten O; Nesland JM; Peng Q
Int J Oncol; 2002 Sep; 21(3):577-82. PubMed ID: 12168102
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Physical Pretreatment Regimens to Enhance Protoporphyrin IX Uptake in Photodynamic Therapy: A Randomized Clinical Trial.
Bay C; Lerche CM; Ferrick B; Philipsen PA; Togsverd-Bo K; Haedersdal M
JAMA Dermatol; 2017 Apr; 153(4):270-278. PubMed ID: 28146245
[TBL] [Abstract][Full Text] [Related]
16. Protoporphyrin IX photobleaching during the light irradiation phase of standard dermatological methyl-aminolevulinate photodynamic therapy.
Tyrrell J; Campbell S; Curnow A
Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):232-8. PubMed ID: 21112545
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
[TBL] [Abstract][Full Text] [Related]
18. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
Tyrrell J; Campbell SM; Curnow A
Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
[TBL] [Abstract][Full Text] [Related]
19. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
Gronlund-Pakkanen S; Wahlfors J; Makinen K; Pakkanen TM; Talja M; Ala-Opas M; Alhava E; Moore RB
J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
[TBL] [Abstract][Full Text] [Related]
20. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Tyrrell JS; Morton C; Campbell SM; Curnow A
Br J Dermatol; 2011 Jun; 164(6):1362-8. PubMed ID: 21564050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]